Changes in Plasma Cholinesterase Activity and Mivacurium Neuromuscular Block in Response to Normothermic Cardiopulmonary Bypass

The effect of reduced plasma cholinesterase (ChE) activity in response to normothermic cardiopulmonary bypass (CPB) on mivacurium neuromuscular block was studied in nine patients anesthetized with propofol/fentanyl.Mivacurium was injected intravenously as an initial bolus of 150 micro gram/kg; repeat doses of 75 micro gram/kg were given when the evoked twitch tension attained 75% of control. With the institution of CPB, the previously normal ChE activity was reduced by 42% and remained low until the end of the procedure. The times of onset (time from the end of injection to maximum neuromuscular block) of the maintenance doses of mivacurium were 26% longer during than before or after CPB (P < 0.05). Their DUR25% (time from end of injection to recovery of neuromuscular transmission to 25% of control) were 13 +/- 3 min (X +/- SD) before, 14 +/- 4 min during, and 16 +/- 4 min (P < 0.05) after CPB. It is concluded, that, although markedly reducing the patient's previously normal ChE activity, normothermic CPB had little effect on the time characteristics of mivacurium neuromuscular block. (Anesth Analg 1995;80:1088-91)

[1]  G. Russell,et al.  The effect of cardiopulmonary bypass on cholinesterase activity , 1993, Anaesthesia.

[2]  L. Skovgaard,et al.  Influence of plasma cholinesterase activity on recovery from mivacurium-induced neuromuscular blockade in phenotypically normal patients. , 1993, Acta anaesthesiologica Scandinavica.

[3]  M. Abel,et al.  Greater neuromuscular blocking potency of atracurium during hypothermic than during normothermic cardiopulmonary bypass. , 1992, Anesthesia and analgesia.

[4]  L. Skovgaard,et al.  Influence of plasma cholinesterase activity on recovery from mivacurium‐induced neuromuscular blockade in phenotypically normal patients , 1992 .

[5]  W. Buzello,et al.  Mivacurium: Dose‐Response Relationship and Administration by Repeated Injection or Infusion , 1992, Anesthesia and analgesia.

[6]  R. Welch,et al.  In Vitro Metabolism of Mivacurium Chloride (BW B1090U) and Succinylcholine , 1989, Anesthesia and analgesia.

[7]  H. H. Ali,et al.  Clinical pharmacology of mivacurium chloride (BW B1090U) infusion: comparison with vecuronium and atracurium. , 1988, British journal of anaesthesia.

[8]  H. H. Ali,et al.  The Clinical Neuromuscular Pharmacology of Mivacurium Chloride (BW B1090U). A Short‐acting Nondepolarizing Ester Neuromuscular Blocking Drug , 1988, Anesthesiology.

[9]  J. Viby-Mogensen Correlation of succinylcholine duration of action with plasma cholinesterase activity in subjects with the genotypically normal enzyme. , 1980, Anesthesiology.

[10]  L. Walts The “Boomerang” — A method of recording adductor pollicis tension , 1973, Canadian Anaesthetists' Society journal.

[11]  K. Courtney,et al.  A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.

[12]  A. Howitt The Boomerang , 2022, Nature.